<DOC>
	<DOCNO>NCT01542385</DOCNO>
	<brief_summary>The PRIMACY trial seek ass whether strategy delay stent implantation combine adjunctive anticoagulation superior immediate stent implantation improve cardiovascular outcome patient mechanically reperfused ST-elevation Myocardial Infarction ( STEMI ) . The investigator hypothesize delayed stent implantation combine systemic anticoagulation maximal antiplatelet therapy reduce combine occurrence cardiac death , non-fatal myocardial infarction , congestive heart failure , target vessel revascularization 90 day .</brief_summary>
	<brief_title>Primary Reperfusion Secondary Stenting Trial</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Age 18 80 year ; 2 . STEMI , present within 12 hour symptoms onset , persist 20 minute ; 3 . ECG fulfill follow criterion : ≥ 2 mm ST elevation two anterior lateral lead ; ≥ 1 mm ST elevation two inferior lead ; new leave bundle branch block ( LBBB ) least 1 mm concordant ST elevation ; 4 . Infarctrelated artery TIMI flow 0 1 baseline angiogram ; 5 . Successful reperfusion ( TIMI 23 flow ) , either spontaneously wire passage , thrombectomy , small size ( ≤ 2.0mm ) angioplasty catheter , persist 10 minute ; 6 . Infarct related artery diameter 2.5 mm . 1 . Prior STEMI qualify coronary artery ; 2 . Coronary dissection follow reperfusion ; 3 . STEMI cause acute stent thrombosis venous arterial bypass graft occlusion ; 4 . Significant leave main disease , determine angiography ( ≥ 50 % ) imaging technology ; 5 . Cardiac condition require emergent urgent surgical repair ; 6 . Failed thrombolysis rescue PCI ; 7 . High risk bleeding ; 8 . Contraindication either ticagrelor GpIIb/IIIa inhibitor ; 9 . STEMI Killip IIIIV cardiogenic shock present sudden death , ventricular fibrillation , sustain ventricular tachycardia ; 10 . Women pregnant breastfeeding ; 11 . Creatinine clearance &lt; 20 ml/min ; 12 . Other contraindication PCI ; 13 . Participation another investigational drug investigational device study within 30 day prior randomization ( participation registry allow ) ; 14 . Any condition opinion investigator would preclude compliance study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Delayed stenting</keyword>
	<keyword>Deferred stenting</keyword>
	<keyword>Late stenting</keyword>
	<keyword>postpone stenting</keyword>
	<keyword>Thrombectomy</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>PCI</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>STEMI</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>